Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EF-hand containing proteins are a large and structurally diverse superfamily defined by the presence of the EF-hand motif, a helix–loop–helix structural domain that binds calcium ions with high selectivity, mediating processes ranging from calcium signaling to buffering[1][2][3][5][6]. Members include calmodulin, troponin C, parvalbumin, S100 family, and many others, with functions spanning from regulatory (signal transduction via conformational change upon Ca2+ binding) to structural (buffering intracellular calcium without major conformational change)[2][5][6]. This is not a single protein or "target" in the sense used for drug discovery, but rather a defining motif within many functionally specialized proteins; thus, listing the family alone ("EF-hand containing proteins") is too broad to match specific therapeutic targeting or indication[1][5]. As a family, there are no broadly interacting compounds; some individual members such as calmodulin have interacting compounds (e.g., trifluoperazine), but the entire group is not broadly targetable. "EF-hand containing proteins" is an imprecise entry if used as a druggable target; it refers to a protein superfamily, not an individual molecular entity. For drug discovery or biomarker use, a specific protein such as "Calmodulin" or "S100B" should be used[1][5][6].
Calcium binding induces conformational changes, modulating interaction with various target proteins[2][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EF-hand containing protein.